Document is current

Any future updates will be listed below

COPD patients with non-small cell lung cancer respond better to anti-PD-(L)1 immune checkpoint inhibitors

Crossref DOI link: https://doi.org/10.1038/s41598-025-02251-0

Published Online: 2025-05-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark